Resources

Sector Reports 2018-05-11T21:16:02+00:00

To make it easier for you to stay on top of key healthcare sectors, the Bourne Partners team generates an ongoing series of comprehensive market analyses, covering macro industry trends, financial performance, deal activity, and other relevant topics.

Aug
23

To take a deeper dive in to what we’ve seen so far in 2022 and our outlook for the second half of the year, read our full Pharma Sector Snapshot. Even with regulatory headwinds and a challenging economic environment, quality assets are trading at premium valuations.  As we move into the second half of 2022, Big Pharma balance sheets are flush with cash and we expect to see sustained M&A interest as investors continue to deploy capital into private markets.

Compare to our 1H 2022 Pharma Sector Snapshot here.

Click here to view this report in its entirety.
Aug
9

To take a deeper dive in to what we’ve seen so far in 2022 and our outlook for the second half of the year, read our full Pharma Sector Snapshot. Even with regulatory headwinds and a challenging economic environment, quality assets are trading at premium valuations.  As we move into the second half of 2022, Big Pharma balance sheets are flush with cash and we expect to see sustained M&A interest as investors continue to deploy capital into private markets.

Compare to our 1H Pharma Services Sector Snapshot here.

Click here to view this report in its entirety.
Jun
30

The 2022 Q2 Consumer Health Sector Snapshot reports the latest industry trends for the Consumer Health sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our Q1 2021 Consumer Health Sector Snapshot here.

Click here to view this report in its entirety.
Apr
30

Off-site GMP biopharma storage providers serve as a critical resource for biopharmaceutical companies and contract development and manufacturing organizations (“CDMOs”) facing storage and overflow issues. This Market Insight report includes the latest industry trends in Biostorage Services as well as trading comps, and transaction comps.

Read our Market Insight report on Biopharmaceutical CDMOs here.

Click here to view this report in its entirety.
Apr
19

Through discussions with our key industry partners and our robust activity in the M&A markets, we’ve seen pent-up demand for high-quality assets in the eClinical Solutions and ancillary Clinical Trial Services space. This Market Insight report includes an in-depth analysis of key market trends, segmentation, and active players in the eClinical space.

The eClinical Solutions market has reached an inflection point, spurred by the onset of the COVID-19 pandemic which accelerated an inevitable shift toward decentralized clinical research methods, the increasing availability and application of innovative technology solutions which promote trial efficiency, and pent-up demand from investors (both strategic and financial) to continue funding high-quality, innovative assets at attractive valuations across the sector.

Read our eClinical & Ancillary Clinical Trial Services Report report here.

Click here to view this report in its entirety.
Jan
1

The 2021 Year End Pharma Services Sector Snapshot reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to our 2022 Q1, Q2, and Q3 Pharma Services Sector Snapshots.

Click here to view this report in its entirety.
Nov
29

The 2021 Q3 Specialty and Generic Pharma Sector Snapshot reports the latest industry trends for the Specialty and Generic Pharma sectors. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to our Q1 and Q2 2021 Specialty and Generic Pharma Sector Snapshots.

Click here to view this report in its entirety.
Oct
25

The 2021 Q3 Pharma Services Sector Snapshot reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to our Q1 and Q2 2021 Pharma Services Sector Snapshots.

Click here to view this report in its entirety.
Aug
31

The 2021 Q2 Specialty and Generic Pharma Sector Snapshot reports the latest industry trends for the Specialty and Generic Pharma sectors. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to our Q1 2021 Specialty and Generic Pharma Snapshot here.

Click here to view this report in its entirety.
Aug
16

The 2021 Q2 Pharma Services Sector Snapshot reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our Q1 2021 Pharma Services Sector Snapshot here.

Click here to view this report in its entirety.
Jun
2

The 2021 Q1 Specialty and Generic Pharma Sector Snapshot reports the latest industry trends for the Specialty and Generic Pharma sectors. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our Q3 2019 Specialty and Generic Pharma Sector Snapshot here.

Click here to view this report in its entirety.
Jun
1

The 2021 Q1 Consumer Health Sector Snapshot reports the latest industry trends for the Consumer Health sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our Q2 2020 Consumer Health Sector Snapshot here.

Click here to view this report in its entirety.
Apr
19

The 2021 Q1 Pharma Services Sector Snapshot reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our 2020 Year End Pharma Services Sector Report here.

Click here to view this report in its entirety.
Jan
5

The 2020 Year End Pharma Services Update reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the 2019 Year End Pharma Services Update to see changes in industry valuations and activity.

Click here to view this report in its entirety.
Oct
15

The 2020 Q3 Pharma Services Sector Snapshot reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

The Pharma Services sector rebounded during the second quarter of 2020 and continued to accelerate during the third quarter. Since the onset of the pandemic and through the trough in March, trading values and multiples for the respective sectors covered in this report are already re-approaching record highs or are at or above historical averages.

To learn more, read our Q1 2020 and 1H 2020 Pharma Services Sector Snapshots.

Click here to view this report in its entirety.
Aug
12

The 2020 Q2 Consumer Health Sector Snapshot reports the latest industry trends for the Consumer Health sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our Q3 2019 Consumer Health Sector Snapshot here.

Click here to view this report in its entirety.
Jul
22

The 1H 2020 Pharmacy Services Sector Snapshot reports the latest industry trends for the Pharmacy Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Since the pandemic-related lows of late March, Contract Services sectors have rebounded significantly. The PBM, Compounding and Spec. Pharmacy and Managed Care sectors have recovered nicely and still trade at strong multiples, and at premiums to their historical averages. Although the #COVID19 pandemic created significant global market volatility, the key indicators for the Pharma and Pharmacy supply chains lead us to remain optimistic.

Read our Q1 2020 Pharmacy Services Sector Snapshot here.

Click here to view this report in its entirety.
Jul
14

The 1H 2020 Pharma Services Sector Snapshot reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our Q1 2020 Pharma Services Sector Snapshot here.

Click here to view this report in its entirety.
Apr
27

The 2019 Q1 Pharma Services Sector Snapshot reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our 2019 Year End Pharma Services Sector Update here.

Click here to view this report in its entirety.
Apr
15

The Q1 2020 Pharmacy Services Sector Snapshot reports the latest industry trends for the Pharmacy Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our 2019 Year End Pharmacy Services Sector Update here.

Click here to view this report in its entirety.
Jan
27

The 2019 Year End Pharmacy Services Update reports the latest industry trends for the Pharmacy Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the Q1, Q2 and Q3 2019 Pharmacy Services Sector Snapshots to see changes in industry valuations and activity.

Click here to view this report in its entirety.
Jan
27

The 2019 Year End Pharma Services Update reports the latest industry trends for the Pharma Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the Q1, Q2 and Q3 2019 Pharma Services Sector Snapshots to see changes in industry valuations and activity.

Click here to view this report in its entirety.
Nov
18

The 2019 Q3 Specialty and Generic Pharma Sector Snapshot reports the latest industry trends for the Consumer Health sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

To learn more, read our Q1 and Q2 Specialty & Generic Pharma Sector Snapshots.

Click here to view this report in its entirety.
Oct
25

The 2019 Q3 Consumer Health Sector Snapshot reports the latest industry trends for the Consumer Health Sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

To learn more, read our Q1 and Q2 Consumer Health Sector Snapshots.

Click here to view this report in its entirety.
Oct
21

The Q3 2019 Pharmacy Services Sector Snapshot reports the latest industry trends for the Pharmacy Services sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Q3 within the Pharmacy Services sector was highlighted by the merger of BioScrip with Option Care Health that will create a leader in the independent home and alternate site infusion services industry. However, the rest of the sector was relatively quiet as valuations slid slightly for the PBM/Managed Care Segment and stabilized for Compounding/Specialty Pharmacies.

To learn more, read our Q1 and Q2 Pharmacy Services Sector Snapshots.

Click here to view this report in its entirety.
Oct
10

The Q3 2019 Pharma Services Sector Snapshot summarizes the performance of CDMOs, CROs, Specialty Packagers, and Distributors. It includes both public market performance and private transactions.

To learn more, read our Q1 and Q2 2019 Consumer Health Sector Snapshots.

Click here to view this report in its entirety.
Aug
13

The primary purpose of this Market Insight update is to evaluate the current status of the Biopharmaceutical Contract Development and Manufacturing (“CDMO”) industry as of 1H 2019. This report serves to further analyze the information provided in Bourne Partners’ Biopharmaceutical CDMOs Analysis Market Insight report from February 2019, as well as to expand upon the drivers and trajectory of the biopharmaceutical CDMO market. The trend of biopharmaceutical CDMO consolidation has continued throughout 1H 2019, with a number of high-profile acquisitions and investments. The increased industry consolidation has been primarily driven by broad growth across the biopharmaceutical sector.

Click here to view this report in its entirety.
Jul
29

The primary purpose of this Market Insight update is to identify three important trends within tech-enabled/ancillary clinical trial services that seek to improve the clinical trial landscape: improvement of patient enrollment efficiency, utilization of wearable technologies, and optimization of the capture and management of additional patient data. These three areas of opportunity will improve the entire spectrum of clinical trials – from patient enrollment, adherence, and retention to improving trial efficiency through new, real-world patient data collection.

Read our eClinical Solutions Market Insight report here.

Click here to view this report in its entirety.
Jul
12

The 2019 Q2 Specialty and Generic Pharma Sector Snapshot summarizes the performance of both product pharma sub-sectors. It includes both public market performance and private transactions. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our Q1 2019 Specialty and Generic Pharma Sector Snapshot here.

Click here to view this report in its entirety.
Jul
8

The 2019 Q2 Consumer Health Sector Snapshot reports the latest industry trends for the Consumer Health Sector. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the 2019 Q2 Consumer Health Sector Snapshot to see changes in industry valuations and activity

Click here to view this report in its entirety.
Jul
1

The 2019 Q2 Pharma Services Sector Snapshot reports the latest industry trends for a wide range of Pharma Services. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Specialty Packaging, and Distribution spaces. The report provides insight into valuation trends and industry performance relative to the S&P 500

Compare to the 2019 Q1 Pharma Services Sector Snapshot to see changes in industry valuations and activity

Click here to view this report in its entirety.
Jun
23

The Q2 Pharmacy Services Sector Snapshot highlights the recent trends and valuations across the Compounding/Specialty Pharmacy and PBM/Managed Care segments. The PBM/Managed Care segment continued its trend of mega-deals with Centene’s proposed $17.3bn acquisition of WellCare, while the nascent Compounding/Specialty Pharmacy segment saw increasing valuations, due in part to increased interest from Private Equity. Moving forward we would expect to see continued interest from Private Equity in both industry sub-segments and for consolidation to drive valuations in the Compounding/Specialty Pharmacy segment as the market matures.

Read our Q1 2019 Pharmacy Services Sector Snapshot here.

Click here to view this report in its entirety.
May
28

This Market Insight report seeks to highlight the key industry trends and growth drivers within the Site Management Organization (“SMO”) and Integrated Site Network (“ISN”) spaces, as well as provide an overall view of the current clinical site and trial services landscape and beyond.

Read our Market Insight report on Pharmaceutical Packaging here.

Click here to view this report in its entirety.
Apr
29

Along with updated valuation comps, this Sports Nutrition Sector Snapshot highlights shifting market dynamics and recent industry trends. Themes include the introduction of private label and exclusive product lines by online retailers, accelerated growth in select developing and established international markets, and perspective on the next waves of innovation in the category.

Read our 2018 Market Insight on the Sports Nutrition Industry here.

Click here to view this report in its entirety.
Apr
15

This 2019 Q1 Specialty and Generic Pharma Sector Snapshot reports the latest industry trends for the Specialty & Generic Pharma Sectors. The report includes comparable trading multiples and recent transactions in adjacent spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our 2018 Market Insight on Branded & Generic Specialty Pharma here.

Click here to view this report in its entirety.
Apr
5

This 2019 Q1 Consumer Health Sector Snapshot reports the latest industry trends for the Consumer Health Sector. The report includes comparable trading multiples and recent transactions in adjacent spaces. The report also provides insight into valuation trends and industry performance relative to the S&P 500.

Read our 2017 Consumer Health Sector Snapshot here.

Click here to view this report in its entirety.
Apr
5

The 2019 Q1 Pharma Services Sector Snapshot reports the latest industry trends for a wide range of Pharma Services. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Distribution, and Clinical Labs spaces. The report provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the 2018 Pharma Services Sector Snapshots to see changes in industry valuations and activity.

Click here to view this report in its entirety.
Apr
3

This Market Insight report covers trends and developments that have had particular impact on the Pharmaceutical Packaging space in 2019. The packaging industry is very sensitive to changes in the broader pharmaceutical market and must adapt to regulatory changes, new and innovative drug delivery systems, and shifting consumer demands and preferences. Based on market research and conversations with pharma executives, industry experts, and investors in the space, this report touches upon a handful of trends we see driving the industry.

Read our Market Insight on Biopharmaceutical CDMOs here.

Click here to view this report in its entirety.
Mar
25

The Q1 Pharmacy Services Sector Snapshot report highlights the latest industry trends for the related subsegments of the sector, including PBM/Managed Care and Compounding/Specialty Pharmacies. After a banner year for M&A in 2018, the beginning of 2019 has been relatively quiet while valuations continue to climb in the PBM/Managed Care space and fall in the Compounding/Specialty Pharmacy sector. The report will provide insight into transactional trends, trading multiples, and relative performance to the broader market.

Read our Q4 2018 Pharma Services Sector Snapshot here.

Click here to view this report in its entirety.
Feb
27

This Market Insight report is an analysis of Biopharmaceutical CDMOs. In a highly competitive industry, the biopharmaceutical CDMOs that are most likely to succeed are those that are willing to adopt cutting edge technology and invest the necessary time and capital to build out differentiated capabilities. The best CDMOs will move quickly to increase capacity while remaining flexible and agile.

Read our 2018 Market Insight on the 2018 Year-End Valuations here.

Click here to view this report in its entirety.
Feb
5

This Market Insight report is an overview of valuations for the Pharma Services, PBM/Managed Care, Compounding/Specialty Pharmacy, Pharma, and Consumer Health markets.

Read our 2018 Market Insight on the Compounding Pharmacy Industry here.

Click here to view this report in its entirety.
Jan
4

The 2018 Q4 Pharma Services Sector Snapshot reports the latest industry trends for a wide range of Pharma Services. The report includes comparable trading multiples and recent transactions in the CDMO, CRO, Distribution, and Clinical Labs spaces. The report provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the Q1, Q2 and Q3 2018 Pharma Services Sector Snapshots to see changes in industry valuations and activity.

Click here to view this report in its entirety.
Jan
3

This report covers the valuation history of the CDMO and CRO Industry over the last 5 years. During this time, CDMO multiples continue to hit record highs as companies pursue consolidation in an effort to become full-service providers. Similarly, CRO multiples remain at historically elevated levels with sponsors continuing to look toward outsourcing as pharma companies find it increasingly difficult to navigate the regulatory landscape.

For additional research in the CRO and CDMO spaces, please review our full sector snapshots.

Click here to view this report in its entirety.
Nov
28

This Market Insight report covers the Compounding Pharmacy Industry in 2018. There are two types of compounding pharmacies, 503A and 503B. A 503A is a compounding pharmacy that makes or alters drugs that are prescribed by doctors for specific patients with needs that can’t be met by commercially available drugs. 503Bs are “outsourcing facilities” that manufacture large batches with or without specific prescription demand to be sold to healthcare facilities for medical office use in hopes of bridging the gap between traditional pharmacy compounding and industrial manufacturing.

In 2017, the Compounding Pharmacies Market as a whole was valued at ~$8.5bn and is expected to grow to ~$12.5bn by 2024, an implied CAGR of ~5.0%. The 503B market currently sits at < $1.5bn.

Read our 2018 Market Insight on the Branded & Generic Specialty Pharma Industry here.

Click here to view this report in its entirety.
Nov
9

This Market Insight report covers Branded & Generic Specialty Pharma in 2018. So far, the specialty pharmaceutical industry has seen many major developments. After years of pain on both the branded side (down 53% from July 2015 highs) and in the generics space (down 46% from peak valuations in April 2015), there are finally signs of stability –and growth –for both.

Read our 2018 Market Insight on the CDMO Industry here.

Click here to view this report in its entirety.
Oct
11

The 2018 Q3 Pharma Services Sector Snapshot reports the latest industry trends for a wide range of Pharma Services. The report includes comparable trading multiples and recent transactions in the CMO, CRO, Distribution, and Clinical Labs spaces. The report provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the Q1 and Q2 2018 Pharma Services Sector Snapshots to see changes in industry valuations and activity.

Click here to view this report in its entirety.
Jul
30

The 2018 Q2 Pharma Services Sector Snapshot reports the latest industry trends for a wide range of Pharma Services. The report includes comparable trading multiples and recent transactions in the CMO, CRO, Distribution, and Clinical Labs spaces. The report provides insight into valuation trends and industry performance relative to the S&P 500.

Compare to the Q1 2018 Pharma Services Sector Snapshot to see changes in industry valuations and activity.

Click here to view this report in its entirety.
May
18

Despite the recent decline in M&A transactions in Q1 2018, activity is expected to ramp up in the second half of 2018. After two years of intense consolidation in the CDMO industry, companies are finding that in order to be successful, they must find new ways to add value. In an attempt to stand out against competition, CDMOs are evolving their businesses to expand beyond core capabilities while moving into adjacent categories.

This Market Insight report examines the dynamic CDMO market landscape and recent M&A activity in the sector.

Read our 2018 Market Insight on the PBM Specialty Pharmacy Industry here.

Click here to view this report in its entirety.
May
8

As more pricing pressure builds, PBMS have maneuvered toward more transparent pricing models to appease regulators and customers despite IQVIA data proving that net brand price growth didn’t match the CPI for the first time in years. Of all PBM services, Medicare Part D and Medicaid have realized significant growth. Sharp increases in specialty drug prices should pay dividends to the greater specialty pharmacy market. Specialty drug spend has materially grown in retail and mail-order channels.

This Market Insight report also features relevant precedent transactions that have occurred in the recent past.

Read our 2017 Market Insight on the PBM Industry here.

Click here to view this report in its entirety.
Apr
25

The 2018 Q1 Pharma Services Sector Snapshot reports the latest industry trends for a wide range of Pharma Services. The report includes comparable trading multiples and recent transactions in the CMO, CRO, Distribution, and Clinical Labs spaces. The report provides insight into valuation trends and industry performance relative to the S&P 500.

Read our 2017 Pharma Services Sector Snapshot here.

Click here to view this report in its entirety.
Apr
20

Both the livestock/farm animal and pet/companion animal segments of the industry have experienced tremendous growth in recent years. This Market Insight includes highlights of key trends and developments shaping the industry as well as an overview of capital markets activity.

Read our 2018 Market Insight on the Sports Nutrition Industry here.

Click here to view this report in its entirety.
Apr
18

Sports nutrition has expanded well beyond the niche bodybuilder demographic to include a broad range of workout and wellness supplements for all ages – and both genders. With a growing population looking to stay fit and balance active lifestyles with healthy diets, this Market Insight report examines the evolving sports nutrition market landscape and recent M&A transactions.

Read our 2018 Market Insight on the Animal Health Market here.

Click here to view this report in its entirety.
Jun
24

The June 2017 Pharma Services Sector Snapshot reports the latest industry trends for Pharma Services. The report includes recent transactions in the CMO, CRO, and Distribution spaces. The report provides insight into valuation trends and industry performance relative to the S&P 500.  

Read our 2017 Consumer Health Sector Snapshot here.

Click here to view this report in its entirety.
Jun
22

The pharmacy benefit manager sector remains highly fragmented with a few dominant players competing for the largest payers and the remainder of firms in the space battling for smaller health plans. Due to escalating healthcare costs, manufacturers and some regulators continually point a finger in PBMs direction despite evidence to the contrary.

Recent valuations for PBMs and related subsectors have diminished slightly in the last twelve months back to historic norms. Despite this decrease, these companies haven’t experienced the same levels of volatility as most pharmaceutical companies.

This industry snapshot includes both precedent transaction comps and public trading comps for PBMs and companies in tangential sub-sectors, as well as valuation and market trends in the overall PBM space.

Read our 2017 Consumer Health Sector Snapshot here.

Click here to view this report in its entirety.
May
2

With the global market for consumer health products in excess of $200bn, the sector is expected to continue to grow at a rapid pace driven by increased awareness around personal health, growing preference for over the counter medical remedies over prescription drugs, and the potential for decreased regulation around consumer health products.

Consumer health companies are seeing high valuations in both the public markets and M&A markets. This is largely driven by 2 factors: scarcity of quality brands with a loyal customer base and increased interest from pharmaceutical companies to diversify product portfolios into the consumer health space. Given factors on both the supply of and demand for consumer health products, we expect valuations to remain healthy.

This Consumer Health Sector Snapshot includes additional information on both the public markets and recent transactions in the consumer health space.

Read our 2016 Consumer Health Sector Report here.

Click here to view this report in its entirety.
Dec
2

This 2016 Specialty Pharmaceutical Sector Report includes a detailed market overview, current market trends, headwinds and tailwinds facing industry participants, industry trading and transaction comps, recent deal profiles, and a collection of future growth drivers within the space.

The specialty pharmaceutical sector continues to offer strong future growth as specialty pharmaceuticals become an ever increasing piece of the global healthcare puzzle. Worldwide Spec Pharma sales reached $655 billion in 2015. Prescription drug sales are expected to reach almost one trillion dollars by 2020 (CAGR: 4.8% between 2014 and 2020).

Despite a decrease in equity performance over the last twelve months, the Spec Pharma market has experienced high growth in the last five years. After a spike in M&A activity and record-high multiples in 2014 and 2015, the market has returned to normalized levels. The recent slowdown can also be attributed to the negative publicity surrounding pricing practices, which has become a political issue in the election year.

Read our 2016 Consumer Health Sector Report here.

Click here to view this report in its entirety.
Feb
3

The consumer health market is comprised of OTC products (48%), nutraceuticals (41%), weight management products and other (7%), and sports nutrition products (4%). Both the OTC market and nutraceuticals market are broken out individually throughout this Consumer Health Sector Report.

Increases in global healthcare costs are leading more individuals to focus on preventative care, self diagnosis, and self medication. US households spend an average of $340 per year on Consumer Health products, and research shows that 81% of adults use Consumer Health products as a first response to minor ailments. Physicians say that 10% of visits to their offices – millions of unnecessary appointments – each year could be avoided by treating common ailments with OTC medicines.

The nutraceutical market is being utilized to augment an increasingly robust OTC market, and growing competition among market participants has led to industry consolidation and a frothy M&A environment. High growth rates and attractive margins have fueled interest from “Big Pharma/Food” companies, eager to enter the market through strategic acquisition. Recent years have seen acquisitions, joint ventures and partnerships between and among industry players accelerate, particularly in the Nutrition segment.

Click here to view this report in its entirety.